Cel AI PLC (CLAI) - Total Liabilities
Based on the latest financial reports, Cel AI PLC (CLAI) has total liabilities worth GBX58.36K GBX (≈ $7.10 USD) as of February 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Cel AI PLC cash flow conversion to assess how effectively this company generates cash.
Cel AI PLC - Total Liabilities Trend (2019–2024)
This chart illustrates how Cel AI PLC's total liabilities have evolved over time, based on quarterly financial data. See what is Cel AI PLC's book value for net asset value and shareholders' equity analysis.
Cel AI PLC Competitors by Total Liabilities
The table below lists competitors of Cel AI PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Verici Dx Plc
LSE:VRCI
|
UK | GBX2.06 Million |
|
Abacus Global Management, Inc.
NASDAQ:ABX
|
USA | $479.34 Million |
|
XTC Lithium Limited
AU:XTC
|
Australia | AU$5.02 Million |
|
Delta Electronics (Thailand) Public Company Limited
F:DLS
|
Germany | €57.40 Billion |
|
Mondee Holdings Inc.
NASDAQ:MONDQ
|
USA | $358.69 Million |
|
Sancus Lending Group Ltd
LSE:LEND
|
UK | GBX158.72 Million |
|
Goldstone Resources Ltd
LSE:GRL
|
UK | GBX13.23 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Cel AI PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see CLAI stock market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cel AI PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cel AI PLC (2019–2024)
The table below shows the annual total liabilities of Cel AI PLC from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-08-31 | GBX140.43K ≈ $17.09 |
-24.42% |
| 2023-08-31 | GBX185.80K ≈ $22.61 |
-33.44% |
| 2022-08-31 | GBX279.13K ≈ $33.96 |
+39.39% |
| 2021-08-31 | GBX200.25K ≈ $24.36 |
+9.85% |
| 2020-08-31 | GBX182.29K ≈ $22.18 |
+594.44% |
| 2019-08-31 | GBX26.25K ≈ $3.19 |
-- |
About Cel AI PLC
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare products. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United King… Read more